Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: Findings and implications-Reference-Cited by-同舟云学术

Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: Findings and implications

Published:2018-03-01 Issue:1 Volume:54 Page:49-56
ISSN:2090-5068
Container-title:Alexandria Journal of Medicine
language:en
Short-container-title:Alexandria Journal of Medicine

Author:

Mataranyika P.A.¹,Kibuule D.¹,Kalemeera F.²,Kaura H.³,Godman B.⁴⁵⁶,Rennie T.W.¹

Affiliation:

1. School of Pharmacy, Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Box 13301 , 340 Mandume Ndemufayo Avenue Pioneers Park, Windhoek, Namibia

2. Department of Pharmacology and Therapeutics, Faculty of Health Sciences, University of Namibia, Box 13301 , 340 Mandume Ndemufayo Avenue Pioneers Park, Windhoek, Namibia

3. Institute of Pathology, Katutura Hospital Complex, Box 277, Windhoek, Namibia

4. Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden

5. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK

6. Liverpool Health Economics Centre, University of Liverpool Management School, Liverpool L69 7ZH, United Kingdom

Funder

National Institute of Pathology of Namibia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1016/j.ajme.2017.03.002

Reference32 articles.

1. Antiretroviral drug toxicity – a challenge for the hepatologist?

2. Adverse Effects and Regimen Switch among Patients on Antiretroviral Treatment in a Resource Limited Setting in Ethiopia

3. The Safety and Efficacy of Tenofovir DF in Combination with Lamivudine and Efavirenz Through 6 Years in Antiretroviral-Naïve HIV-1—Infected Patients